Operating Cash Flow (Statement)

$492.60M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$492.60Mperiod endingJun 30, 2026

BIO TTM Cash from Operations ($12.10M → $492.60M)

TTM operating cash flow (statement)

High-resolution chart · PNG

BIO operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	49,281,000
Mar 31, 2001	32,284,000
Dec 31, 2000	24,247,000
Sep 30, 2000	40,465,000
Jun 30, 2000	43,865,000
Mar 31, 2000	37,778,000
Dec 31, 1999	45,000,000
Sep 30, 1999	34,300,000
Jun 30, 1999	33,000,000
Mar 31, 1999	28,800,000
Dec 31, 1998	27,300,000
Sep 30, 1998	20,500,000
Jun 30, 1998	21,900,000
Mar 31, 1998	21,700,000
Dec 31, 1997	21,100,000
Sep 30, 1997	25,000,000
Jun 30, 1997	16,500,000
Mar 31, 1997	24,100,000
Dec 31, 1996	33,200,000
Sep 30, 1996	39,600,000
Jun 30, 1996	43,400,000
Mar 31, 1996	38,100,000
Dec 31, 1995	38,200,000
Sep 30, 1995	34,800,000
Jun 30, 1995	37,100,000
Mar 31, 1995	41,800,000
Dec 31, 1994	48,300,000
Sep 30, 1994	57,400,000
Jun 30, 1994	54,600,000
Mar 31, 1994	39,600,000
Dec 31, 1993	22,500,000
Sep 30, 1993	-8,800,000
Jun 30, 1993	5,200,000
Mar 31, 1993	4,200,000
Dec 31, 1992	4,000,000
Sep 30, 1992	21,700,000
Jun 30, 1992	2,100,000
Mar 31, 1992	5,700,000
Dec 31, 1991	4,100,000
Sep 30, 1991	-300,000
Jun 30, 1991	5,100,000
Mar 31, 1991	3,800,000
Dec 31, 1990	12,100,000
Sep 30, 1990	13,200,000
Jun 30, 1990	14,700,000